Management

Edward Lee, PhD

Vice President
Chemistry, Manufacturing and Controls
(CMC)

Edward Lee joined Aviragen Therapeutics on August 4th 2014.

Dr. Edward R Lee was Vice President and Head of Chemical Development at Blend Therapeutics from April 2012 until November 2013, where novel platinum compounds and nanotechnology were combined to create innovative oncology therapies. Prior to that, he was Vice President and Head of Chemical Process Development at Genzyme Corporation. In a career spanning 22 years at Genzyme he was responsible for the development of small molecules and polymers to treat numerous diseases, including cystic fibrosis, multiple sclerosis and Gaucher Disease. Edward held a post-doctoral position at the University of Bern, Switzerland, from 1988 to1990, investigating vitamin B12 chemistry.

Dr. Lee received a BSc in Chemistry from the University of Warwick, UK and a PhD in Chemistry from the University of Warwick, UK.

Log In

Create an account